DigitalOcean shares rise as investors position ahead of Q1 earnings and recent AI product announcements

DigitalOcean Holdings, Inc. (DOCN) is up 4.0% today. Here is some analysis on what might have caused this price movement.

Analysis: The move appears tied to pre-earnings positioning ahead of DigitalOcean’s Q1 2026 results, which are scheduled for release before the market opens on May 5, 2026. Recent company announcements around new AI inference capabilities may also be supporting sentiment into the print.

Details:

DigitalOcean said it plans to report first-quarter 2026 financial results before market open on Tuesday, May 5, 2026, followed by a morning conference call.

In late April, the company announced new “Inference Engine” capabilities aimed at helping AI teams run and optimize inference workloads, including a routing feature intended to reduce cost and improve efficiency for agentic workloads.

In its most recent full-year results release, DigitalOcean highlighted strengthening AI traction and raised its outlook for 2026 and 2027, framing AI-related services as a growing contributor to ARR.

This could also reflect a broader risk-on bid in software/AI infrastructure names ahead of a key catalyst, with short-term flows amplifying the move.

Sources:

DigitalOcean Investor Relations, DigitalOcean press release, StockAnalysis

Disclaimer: This price movement analysis was generated with the help of AI. Please double-check the information provided for mistakes.

$DOCN Insider Trading Activity

$DOCN insiders have traded $DOCN stock on the open market 2 times in the past 6 months. Of those trades, 0 have been purchases and 2 have been sales.

Here’s a breakdown of recent trading of $DOCN stock by insiders over the last 6 months:

CHERIE BARRETT (SVP, Chief Accounting Officer) sold 22,000 shares for an estimated $1,204,940
MATT STEINFORT (Chief Financial Officer) sold 20,000 shares for an estimated $1,108,000

To track insider transactions, check out Quiver Quantitative's insider trading dashboard. You can access data on insider stock transactions through the Quiver Quantitative API.

$DOCN Hedge Fund Activity

We have seen 209 institutional investors add shares of $DOCN stock to their portfolio, and 158 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

UBS GROUP AG added 1,573,245 shares (+338.4%) to their portfolio in Q4 2025, for an estimated $75,704,549
BALYASNY ASSET MANAGEMENT L.P. removed 838,724 shares (-73.6%) from their portfolio in Q4 2025, for an estimated $40,359,398
NORGES BANK removed 792,480 shares (-100.0%) from their portfolio in Q4 2025, for an estimated $38,134,137
LAZARD ASSET MANAGEMENT LLC removed 776,966 shares (-50.4%) from their portfolio in Q4 2025, for an estimated $37,387,603
MARSHALL WACE, LLP removed 705,917 shares (-96.4%) from their portfolio in Q4 2025, for an estimated $33,968,726
ALYESKA INVESTMENT GROUP, L.P. removed 638,401 shares (-100.0%) from their portfolio in Q4 2025, for an estimated $30,719,856
LMR PARTNERS LLP added 620,000 shares (+inf%) to their portfolio in Q4 2025, for an estimated $29,834,400

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API.

$DOCN Analyst Ratings

Wall Street analysts have issued reports on $DOCN in the last several months. We have seen 2 firms issue buy ratings on the stock, and 0 firms issue sell ratings.

Here are some recent analyst ratings:

B of A Securities issued a "Buy" rating on 11/06/2025
Canaccord Genuity issued a "Buy" rating on 11/06/2025

To track analyst ratings and price targets for $DOCN, check out Quiver Quantitative's $DOCN forecast page.

$DOCN Price Targets

Multiple analysts have issued price targets for $DOCN recently. We have seen 11 analysts offer price targets for $DOCN in the last 6 months, with a median target of $105.0.

Here are some recent targets:

David Hynes from Canaccord Genuity set a target price of $120.0 on 05/01/2026
Timothy Horan from Oppenheimer set a target price of $115.0 on 04/28/2026
Mark Zhang from Citigroup set a target price of $115.0 on 04/28/2026
Raimo Lenschow from Barclays set a target price of $105.0 on 04/21/2026
Radi Sultan from UBS set a target price of $97.0 on 04/21/2026
Wamsi Mohan from B of A Securities set a target price of $107.0 on 04/09/2026
James Fish from Piper Sandler set a target price of $98.0 on 04/07/2026

This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.